Showing results (1911-1920 of 2,009) with videos related to

Sort By:
Pageof 201
Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
BMC Women'S Health|September 13, 2021
Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort studyMargo E Pearce, Sofia R Bartlett, Amanda Yu, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromasValentina Pinna, Valentina Lanari, Paola Daniele, et al.
Frontiers in Oncology|July 26, 2021
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb StudiesAntonio Passaro, Filippo de Marinis, Hai-Yan Tu, et al.
BJS Open|January 3, 2024
Abdominal drainage after elective colorectal surgery: propensity score-matched retrospective analysis of an Italian cohortStefano Guadagni, Marco Catarci, Francesco Masedu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatmentClaudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Nature Chemistry|July 18, 2025
Navigating protein landscapes with a machine-learned transferable coarse-grained modelNicholas E Charron, Klara Bonneau, Aldo S Pasos-Trejo, et al.
Expert Opinion on Drug Safety|November 24, 2016
Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switchConcetta Rafaniello, Marco Pozzi, Simone Pisano, et al.
Contemporary Clinical Trials|March 14, 2023
Cognitive-behavioral therapy and exercise training in adolescent females with elevated depression symptoms and at-risk for type 2 diabetes: Protocol for a randomized controlled trialAna M Gutierrez-Colina, Madison Bristol, Emma L M Clark, et al.
Npj Aging|June 5, 2026
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8+ T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trialPanayota Kolypetri, Patrick da Silva, Ronaldo S Francisco, et al.
Pageof 201